Cell cultures - Import export

Contact Korea was founded in 2001 and sells and manufactures medical devices. In 2001, the world's No. 1 product, Restylane, was first launched in Korea as an HA filler, pioneering the field of fillers in the cosmetic surgery industry, and developing injection filler for pediatric urinary disorders (VUR). Since 2015, we have participated in research and development and manufacture of medical devices in earnest and developed indirect drug injector, various dermal fillers, and multi-needles and exporting them to 19 countries. And in 2023, we are jointly developing exosomes, a key substance in stem cell culture, with bio-venture company and aim to export 200% growth within two years.